Z H McMahan1, D Khanna2. 1. Johns Hopkins University, Division of Rheumatology, Baltimore, MD, USA. 2. University of Michigan, Division of Rheumatology, Ann Arbor, MI, USA.
Abstract
OBJECTIVE: We sought to critically evaluate the literature published over the past 3 years on the management of gastrointestinal complications in systemic sclerosis (SSc). We emphasize interesting and important new findings to bring the reader up-to-date. We also discuss controversial discoveries and hypotheses currently of interest. METHODS: We conducted a literature search on PubMed over the last 3 years using the key words "systemic sclerosis," "gastrointestinal," "scleroderma," and "treatment." We also screened clinicaltrials.gov for ongoing trials relevant to the gastrointestinal complications of SSc. Reference lists from recent reviews on the management of gastrointestinal complications of SSc to identify articles that might have been missed in the initial search. RESULTS: 103 publications and ongoing clinical trials were identified. We eliminated all case reports and review articles. Ultimately we had 58 articles remaining and we prioritized what we found to be the strongest and/or novel findings to discuss in this review. CONCLUSIONS: Advances in the management of gastrointestinal disease in SSc continue to evolve. The application of novel therapies and the repurposing of existing therapies for the management of gastrointestinal involvement are shaping the therapeutic arsenal so that we can more effectively manage these complex patients.
OBJECTIVE: We sought to critically evaluate the literature published over the past 3 years on the management of gastrointestinal complications in systemic sclerosis (SSc). We emphasize interesting and important new findings to bring the reader up-to-date. We also discuss controversial discoveries and hypotheses currently of interest. METHODS: We conducted a literature search on PubMed over the last 3 years using the key words "systemic sclerosis," "gastrointestinal," "scleroderma," and "treatment." We also screened clinicaltrials.gov for ongoing trials relevant to the gastrointestinal complications of SSc. Reference lists from recent reviews on the management of gastrointestinal complications of SSc to identify articles that might have been missed in the initial search. RESULTS: 103 publications and ongoing clinical trials were identified. We eliminated all case reports and review articles. Ultimately we had 58 articles remaining and we prioritized what we found to be the strongest and/or novel findings to discuss in this review. CONCLUSIONS: Advances in the management of gastrointestinal disease in SSc continue to evolve. The application of novel therapies and the repurposing of existing therapies for the management of gastrointestinal involvement are shaping the therapeutic arsenal so that we can more effectively manage these complex patients.
Authors: Kristina E N Clark; Oseme Etomi; Christopher P Denton; Voon H Ong; Charles D Murray Journal: Clin Exp Rheumatol Date: 2015-08-27 Impact factor: 4.473
Authors: Elizabeth R Volkmann; Anna-Maria Hoffmann-Vold; Yu-Ling Chang; Jonathan P Jacobs; Kirsten Tillisch; Emeran A Mayer; Philip J Clements; Johannes R Hov; Martin Kummen; Øyvind Midtvedt; Venu Lagishetty; Lin Chang; Jennifer S Labus; Øyvind Molberg; Jonathan Braun Journal: BMJ Open Gastroenterol Date: 2017-04-01